Modeled CA-125 kinetics during neoadjuvant chemotherapy for predicting the likelihood of optimal interval debulking surgery in ovarian cancer patients: Data from CHIVA trial (a GINECO study).

Authors

null

Patrick Robelin

Hospices Civils de Lyon, Pierre-Bénite, France

Patrick Robelin , Michel Tod , Olivier Colomban , Christophe Louvet , Jean-Pierre Lotz , Sophie Abadie Lacourtoisie , Michel Fabbro , Christophe Desauw , Nathalie Bonichon , Jean Emmanuel Kurtz , Philippe Follana , Marianne Leheurteur , Francesco Del Piano , Carol René Alliot , Gaetan De Rauglaudre , Isabelle Laure Ray-Coquard , Pierre Combe , Annick Chevalier , Florence Joly , Benoit You

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

2011-006288-23

Citation

J Clin Oncol 37, 2019 (suppl; abstr 5546)

DOI

10.1200/JCO.2019.37.15_suppl.5546

Abstract #

5546

Poster Bd #

369

Abstract Disclosures

Similar Posters

Poster

2019 ASCO Annual Meeting

Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer.

Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer.

First Author: Ying L Liu

First Author: Mingyi Zhou